Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • RAAS
    (4)
  • Autophagy
    (1)
  • MRP
    (1)
  • NMDAR
    (1)
  • Others
    (18)
Filter
Search Result
Results for "

alap

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    28
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    3
    TargetMol | Isotope_Products
Goxalapladib
GSK 677116
T67799412950-27-7In house
Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
  • $195
In Stock
Size
QTY
Alaproclate
T6901360719-82-6In house
Alaproclate is a non-competitive NMDA receptor antagonist and a new selective 5-HT uptake inhibitor for the study of depression and dementia.
  • $293
In Stock
Size
QTY
Enalapril IMpurity B
(+)-N-[1-(S)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine
T168982717-96-2
Enalapril IMpurity B ((+)-N-[1-(S)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine) is Moexipril intermediate and is the main metabolite of Imidapril.
  • $29
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Enalapril Maleate
MK-421 Maleate, Renitec Maleate, Glioten Maleate, MK-421 (maleate), Vasotec Maleate
T648676095-16-4
Enalapril Maleate (MK-421 Maleate), an angiotensin-converting enzyme (ACE) inhibitor, is utilized in the treatment of hypertension, chronic heart failure , and diabetic nephropathy.
  • $42
In Stock
Size
QTY
Enalapril D5 maleate
MK-421 D5 maleate
T11192349554-02-5
Enalapril D5 maleate is deuterium labeled Enalapril, which is an angiotensin converting enzyme (ACE) inhibitor.
  • $177
7-10 days
Size
QTY
Enalaprilat-d5 sodium
MK-422 D5 Sodium Salt,Enalaprilat D5 Sodium Salt
T111931356922-29-6
Enalaprilat D5 Sodium Salt is the deuterium labeled Enalaprilat, which is an angiotensin-converting enzyme (ACE) inhibitor.
  • $227
7-10 days
Size
QTY
Enalaprilat D5
MK-422 D5
T11194349554-00-3
Enalaprilat D5 is the deuterium labeled Enalaprilat, which is an angiotensin-converting enzyme (ACE) inhibitor.
  • $118
7-10 days
Size
QTY
Balapiravir
R1626,Ro 4588161
T14493690270-29-2
Balapiravir (R1626, Ro 4588161) is the prodrug of a nucleoside analogue inhibitor of the hepatitis C virus (HCV) RNA-dependent RNA polymerase (R1479, RG1479). IC50 Value: Target: HCV Balapiravir was discontinued for safety reasons in 28-36% of patients (m
  • $112
5 days
Size
QTY
Enalapril
MK-421
T160575847-73-3
Enalapril is a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.
  • $30
In Stock
Size
QTY
Enalapril sodium
(-)-Enalapril sodium
T1605L149404-21-7
Enalapril sodium is used to treat high blood pressure, diabetic kidney disease, and heart failure and can be generally used with a diuretic such as furosemide for heart failure.
  • $1,520
1-2 weeks
Size
QTY
Reproxalap
NS-2, ADX-102
T16732916056-79-6
Reproxalap (NS-2) covalently binds aldehydes including malondialdehyde and 4-hydroxynonenal. Reproxalap is a reactive aldehyde species sequestering agent for the treatment of the dry eye.
  • $33
In Stock
Size
QTY
Talaporfin sodium
NPe6, Mono-L-aspartyl chlorin e6, ME2906
T16978220201-34-3
Talaporfin is a photosensitizer used in photodynamic therapy.
  • $1,750
4-6 weeks
Size
QTY
Muvalaplin tetrahydrochloride
LY3473329 TeTrahydrochloride
T2004522565656-71-3
Muvalaplin tetrahydrochloride (LY3473329) is an orally active lipoprotein (a)Lp(a) agent currently under investigation. Research on the oral formulation of Muvalaplin tetrahydrochloride is ongoing.
  • Inquiry Price
Size
QTY
Alaproclate hydrochloride, (S)-
T2370157469-92-8
Alaproclate hydrochloride, (S)- is a selective inhibitor of serotonin reuptake.
  • $1,520
6-8 weeks
Size
QTY
Alaproclate, (S)-
(-)-Alaproclate,S-(-)-Alaproclate
T2370266171-75-3
Alaproclate, (S)- is a selective inhibitor of serotonin reuptake.
  • $1,520
6-8 weeks
Size
QTY
Balapiravir hydrochloride
R 1626,Balapiravir HCl,RO-4588161,RO4588161,R-1626,R1626,RO 4588161
T26736690270-65-6
Balapiravir HCl, an NS5B inhibitor, is used potentially for the treatment of HCV infection.
  • $1,820
8-10 weeks
Size
QTY
Atalaphillinine
T3018956296-87-8
Atalaphillinine is an acridone alkaloid.
  • $1,520
Backorder
Size
QTY
Dalapon
Basfapon B,Dowpon M,Dawpon-Rae
T3119475-99-0
Dalapon is a selective herbicide used to control perennial grasses. The major use of dalapon is on food crops including sugarcane and sugar beets. Its use is no longer authorized in France. The National Institute for Occupational Safety and Health in the
  • $1,520
Backorder
Size
QTY
Jalapinolic acid
Jalapinoic Acid, Builic Acid, 11-Hydroxyhexadecanoic acid, 11-Hydroxy Palmitic Acid
T32253502-75-0
Jalapinolic acid (Builic Acid) is a hydroxypalmitic acid.
  • $89
In Stock
Size
QTY
Talaporfin free acid
Talaporfin, Aspartyl chlorin, Monoaspartyl chlorin, NPe6 free acid
T34777110230-98-3
Talaporfin, an effective tumor localizer, can produce the selective degradation of tumor tissue following light exposure.
  • $1,520
6-8 weeks
Size
QTY
Alaproclate (hydrochloride)
T3652160719-83-7
Alaproclate is a selective serotonin reuptake inhibitor (SSRI).1,2 It inhibits depletion of serotonin (5-HT) induced by 4-methyl-α-ethyl-m-tyramine in rat cerebral cortex, hippocampus, hypothalamus, and striatum (EC50s = 18, 4, 8, and 12 mg/kg, respectively).1 Alaproclate inhibits NMDA-evoked currents and depolarization-induced voltage-dependent potassium currents in rat hippocampal neurons (IC50s = 1.1 and 6.9 μM, respectively) and does not inhibit GABA-evoked currents when used at concentrations up to 100 μM.2 It increases sirtuin 1 (SIRT1) levels in N2a murine neuroblastoma cells expressing apolipoprotein E4 (ApoE4; IC50 = 2.3 μM) and in the hippocampus in the FXFAD-ApoE4 transgenic mouse model of Alzheimer's disease when administered at a dose of 20 mg/kg twice daily.3 Alaproclate (40 mg/kg) decreases immobility time in the forced swim test in rats, indicating antidepressant-like activity.4References1. Michael, G.B., Eidam, C., Kadlec, K., et al. Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica. Journal of Antimicrobial Chemotherapy 67(6), 1555-1557 (2012).2. Svensson, B.E., Werkman, T.R., and Rogawski, M.A. Alaproclate effects on voltage-dependent K+ channels and NMDA receptors: Studies in cultured rat hippocampal neurons and fibroblast cells transformed with Kv1.2 K+ channel cDNA. Neuropharmacology 33(6), 795-804 (1994).3. Campagna, J., Soilman, P., Jagodzinska, B., et al. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model. Sci. Rep. 8(1), 17574 (2018).4. Danysz, W.P., A., Kostowski, W., Malatynska, E., et al. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol. Toxicol. 62(1), 42-50 (1988). Alaproclate is a selective serotonin reuptake inhibitor (SSRI).1,2 It inhibits depletion of serotonin (5-HT) induced by 4-methyl-α-ethyl-m-tyramine in rat cerebral cortex, hippocampus, hypothalamus, and striatum (EC50s = 18, 4, 8, and 12 mg/kg, respectively).1 Alaproclate inhibits NMDA-evoked currents and depolarization-induced voltage-dependent potassium currents in rat hippocampal neurons (IC50s = 1.1 and 6.9 μM, respectively) and does not inhibit GABA-evoked currents when used at concentrations up to 100 μM.2 It increases sirtuin 1 (SIRT1) levels in N2a murine neuroblastoma cells expressing apolipoprotein E4 (ApoE4; IC50 = 2.3 μM) and in the hippocampus in the FXFAD-ApoE4 transgenic mouse model of Alzheimer's disease when administered at a dose of 20 mg/kg twice daily.3 Alaproclate (40 mg/kg) decreases immobility time in the forced swim test in rats, indicating antidepressant-like activity.4 References1. Michael, G.B., Eidam, C., Kadlec, K., et al. Increased MICs of gamithromycin and tildipirosin in the presence of the genes erm(42) and msr(E)-mph(E) for bovine Pasteurella multocida and Mannheimia haemolytica. Journal of Antimicrobial Chemotherapy 67(6), 1555-1557 (2012).2. Svensson, B.E., Werkman, T.R., and Rogawski, M.A. Alaproclate effects on voltage-dependent K+ channels and NMDA receptors: Studies in cultured rat hippocampal neurons and fibroblast cells transformed with Kv1.2 K+ channel cDNA. Neuropharmacology 33(6), 795-804 (1994).3. Campagna, J., Soilman, P., Jagodzinska, B., et al. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model. Sci. Rep. 8(1), 17574 (2018).4. Danysz, W.P., A., Kostowski, W., Malatynska, E., et al. Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol. Toxicol. 62(1), 42-50 (1988).
  • TBD
35 days
Size
QTY
Acloproxalap
T602381824609-67-7
Acloproxalap is a quinoline-based aldehyde scavenger used in studies of diseases with toxic aldehyde accumulation, including inflammatory diseases of the eye and skin, respiratory diseases such as pneumonia, organ diseases, and syndromes associated with viral infections[1] [2].
  • $42
5 days
Size
QTY
Enalaprilat Dihydrate
MK-422 Dihydrate
T634084680-54-6
Enalaprilat Dihydrate (MK-422 Dihydrate) (IC50=1.94 nM) is a potent angiotensin-converting enzyme (ACE) inhibitor.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Enalaprilat
MK-422, MK422, MK 421 diacid, Enalapril acid
T6340L76420-72-9
Enalaprilat (Enalapril acid) is a potent angiotensin-converting enzyme (ACE) inhibitor that enhances arterial and cardiopulmonary pressure reflex control of sympathetic activity in patients with heart failure, and can be used in the study of cardiovascular disease.
  • $29
In Stock
Size
QTY